Sort
40,608 grants matching “prostate cancer”
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance
$327,141Daniel W Lin · Fred Hutchinson Cancer Research Center · UH3 · FY2020 · CA
HORMONES: BIOCHEMISTRY AND MOLECULAR BIOLOGY
$327,077Max Elliot Gottesman · Columbia University Health Sciences · T32 · FY2013 · DK
Enhancement of Gene Transfer &Prostate Cancer Immunity
$327,075University Of Iowa · R01 · FY2002 · CA
Extending Reach, Accuracy, and Therapeutic Capabilities: A Soft Robot for Peripheral Early-Stage Lung Cancer
$327,070Sheila Russo · Boston University (Charles River Campus) · R01 · FY2025 · EB
STRUCTURE AND FUNCTION OF HYALURONAN SYNTHASES
$327,020Paul H Weigel · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2012 · GM
The benefits and harms of lung cancer screening in Florida
$327,019Jiang Bian · University Of Florida · R01 · FY2023 · CA
Chemokines, TRP Channels and Cancer Pain
$327,010Durga Prasanna Mohapatra · University Of Iowa · R01 · FY2014 · NS
Genetics of Sex Determination and Cell Death in Plants
$327,000Yale University · R01 · FY2001 · GM
Genetics of Sex Determination and Cell Death in Plants
$327,000Yale University · R01 · FY2002 · GM
Genetics of Sex Determination and Cell Death in Plants
$327,000Yale University · R01 · FY2004 · GM
Community Outreach and Engagement
$327,000Melissa Mazor · Icahn School Of Medicine At Mount Sinai · P30 · FY2025 · CA
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry
$327,000Kenneth J. Pienta · Johns Hopkins University · U01 · FY2017 · CA
Genetics of Sex Determination and Cell Death in Plants
$327,000Yale University · R01 · FY2003 · GM
A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis
$326,999Zijie Sun · Stanford University · R01 · FY2014 · CA
DISSECTING THE ROLE OF GERMLINE ATM LOSS IN THE EVOLUTION OF AGGRESSIVE LOCALIZED PROSTATE CANCER
$326,993The University Of Manchester · · FY2025 · Defense Health Agency
Cannabinoid CB2 Agonists for Treatment of Breast Cancer Induced Bone Pain
$326,992Todd W Vanderah · University Of Arizona · R01 · FY2019 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER
$326,983Henry Ford Health System · N01 · FY2000 · CN
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$326,981Joe W. Gray · Oregon Health & Science University · U2C · FY2019 · CA
AstroPath Integration Resource Core
$326,962Alexander S Szalay · Johns Hopkins University · U54 · FY2022 · CA
International Differences in Health, Longevity, and SES
$326,952James Patrick Smith · Rand Corporation · R01 · FY2011 · AG
Mechanisms of Radioresistance and Cell Cycle Progression
$326,945Howard B Lieberman · Columbia University Health Sciences · R01 · FY2013 · CA
FoxP3 as the X-Linked Breast Cancer Suppressor Gene
$326,913Yang Liu · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Cooperative steroidogenic inhibition for treatment of advanced prostate cancer
$326,897Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA
Cooperative steroidogenic inhibition for treatment of advanced prostate cancer
$326,897Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · CA
Cooperative steroidogenic inhibition for treatment of advanced prostate cancer
$326,897Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA